{"id":54738,"date":"2022-07-22T08:05:43","date_gmt":"2022-07-22T13:05:43","guid":{"rendered":"https:\/\/www.partnershipagainstcancer.ca\/?post_type=corporate-documents&#038;p=54738"},"modified":"2026-07-20T18:18:32","modified_gmt":"2026-07-20T23:18:32","slug":"remuneration","status":"publish","type":"corporate-documents","link":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","title":{"rendered":"R\u00e9mun\u00e9ration"},"content":{"rendered":"\r\n<p class=\"wp-block-paragraph\"><strong>1.<\/strong> Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 18 968 234 $ pour l\u2019ann\u00e9e civile close le 31 d\u00e9cembre 2025.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\"><strong>2.<\/strong> Le nombre total de membres du personnel permanents \u00e0 temps plein au 31 mars 2026 \u00e9tait de 130. \u00c0 l\u2019occasion, le Partenariat fait appel \u00e0 du personnel contractuel pour g\u00e9rer la charge de travail.<\/p>\r\n\r\n\r\n\r\n<p class=\"wp-block-paragraph\"><strong>3. <\/strong> Montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux membres du personnel suivants pour l\u2019ann\u00e9e civile close le 31 d\u00e9cembre 2025 (tel que d\u00e9clar\u00e9 sur les feuillets T4 pour 2025) :<\/p>\r\n<table class=\"table table-bordered\">\r\n<tbody>\r\n<tr class=\"active\">\r\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>Titre <\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>R\u00e9mun\u00e9ration (feuillets T4 pour 2025)<\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"33%\"><strong>Avantages imposables (inclus dans le montant de la r\u00e9mun\u00e9ration)<\/strong><\/th>\r\n<\/tr>\r\n<\/tbody>\r\n<tbody>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Pr\u00e9sident-directeur g\u00e9n\u00e9ral<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">784 688,71 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">4 404,48 $<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Finances et services de l\u2019entreprise<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">303 404,79 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">4 800,83 $<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Partenariats strat\u00e9giques<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">319 411,10 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">4 800,83 $<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente, Syst\u00e8mes de lutte contre le cancer et innovation*<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">263 266,06 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">3 794,73 $<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"302\">Vice-pr\u00e9sidente par int\u00e9rim, Syst\u00e8mes de lutte contre le cancer et innovation**<\/td>\r\n<td style=\"vertical-align: top;\" width=\"124\">222 420,64 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"160\">3 404,08 $<\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n\r\n<p><em><small>* En cong\u00e9 pendant une partie de 2025 (la r\u00e9mun\u00e9ration indiqu\u00e9e comprend les droits de cong\u00e9)<br \/>**Poste de vice-pr\u00e9sidente par int\u00e9rim pour le remplacement de la titulaire durant son cong\u00e9 (comprend le salaire de directrice vers\u00e9 \u00e0 la personne ayant assur\u00e9 l\u2019int\u00e9rim pendant une partie de 2025)<\/small><\/em>\u00a0<\/p>\r\n<p><strong>4.<\/strong> Fourchettes salariales du personnel du Partenariat (en vigueur au 31 mars 2025) :<\/p>\r\n<table class=\"table table-bordered\">\r\n<tbody>\r\n<tr class=\"active\">\r\n<th style=\"vertical-align: top;\" width=\"10%\"><strong>Niveau<\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"40%\"><strong>Poste<\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"40%\"><strong>Fourchette de r\u00e9mun\u00e9ration annuelle<\/strong><\/th>\r\n<th style=\"vertical-align: top;\" width=\"10%\">Nombre de membres du personnel permanent \u00e0 temps plein<\/th>\r\n<\/tr>\r\n<\/tbody>\r\n<tbody>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">9<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Directeur(-trice)<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">131 895 $ \u2013 202 753 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">11<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">8<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Contr\u00f4leur(-euse) de gestion, architecte d\u2019entreprise<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">120 936 $ \u2013 166 466 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">2<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">7<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Gestionnaire, partenaire principal d\u2019affaires en RH, gestionnaire de programme, responsable<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">100 780 $ \u2013 138 721 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">29<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">6<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Analyste, gestionnaire de programme, gestionnaire de service, responsable, sp\u00e9cialiste, conseiller(-\u00e8re), comptable principal(e), d\u00e9veloppeur(-euse) Web, gestionnaire de projet<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">80 624 $ \u2013 109 080 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">56<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">5<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Analyste, agent(e), adjointe de direction au pr\u00e9sident-directeur g\u00e9n\u00e9ral, adjointe de direction \u00e0 la vice-pr\u00e9sidente, Finances et services de l\u2019entreprise\/agente de liaison avec le conseil, adjointe de direction \u00e0 la vice-pr\u00e9sidente, Syst\u00e8mes de lutte contre le cancer et innovation et \u00e0 la vice-pr\u00e9sidente, Partenariats strat\u00e9giques<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">70 723 $ \u2013 95 683 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">14<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">4<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Coordonnateur(-trice)<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">54 419 $ \u2013 73 626 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">10<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\">3<\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">Adjoint(e) administratif(-ive)<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\">47 736 $ \u2013 64 584 $<\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\">4<\/td>\r\n<\/tr>\r\n<tr>\r\n<td style=\"vertical-align: top;\" width=\"60\"><strong>\u00a0<\/strong><\/td>\r\n<td style=\"vertical-align: top;\" width=\"264\">\u00a0<\/td>\r\n<td style=\"vertical-align: top;\" width=\"144\"><strong>T<\/strong><strong>OTAL<\/strong><\/td>\r\n<td style=\"vertical-align: top;\" width=\"118\"><strong>130*<\/strong><\/td>\r\n<\/tr>\r\n<\/tbody>\r\n<\/table>\r\n<p><strong>5.<\/strong> Le montant total de la r\u00e9mun\u00e9ration vers\u00e9e aux membres du conseil d\u2019administration du Partenariat pour l\u2019exercice clos le 31 d\u00e9cembre 2025 (tel que d\u00e9clar\u00e9 \u00e0 l\u2019Agence du revenu du Canada sur les feuillets T4 pour 2025) s\u2019\u00e9levait \u00e0 107 000 $.<\/p>\r\n<h3>R\u00e9mun\u00e9ration du Partenariat<\/h3>\r\n<ul>\r\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2024-25\/\">R\u00e9mun\u00e9ration 2024-2025<\/a><\/li>\r\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2022-23\/\">R\u00e9mun\u00e9ration 2022-2023<\/a><\/li>\r\n<li><a href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/remuneration-2021-22\/\">R\u00e9mun\u00e9ration 2021-2022<\/a><\/li>\r\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2021\/07\/Salary_Disclosure_2020-2021_FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2020-2021<\/a><\/li>\r\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2020\/08\/Compensation-FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2019-2020<\/a><\/li>\r\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2019\/07\/Disclosure_Document_FR.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2018-2019<\/a><\/li>\r\n<li><a href=\"https:\/\/s22457.pcdn.co\/wp-content\/uploads\/2018\/08\/Salaries-and-Disclosure_Fre_Final.pdf\" target=\"_blank\" rel=\"noopener\">R\u00e9mun\u00e9ration 2017-2018<\/a><\/li>\r\n<\/ul>","protected":false},"excerpt":{"rendered":"<p>1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 18 968 234 $ pour l\u2019ann\u00e9e civile close le 31 d\u00e9cembre 2025. 2. Le nombre total de membres du personnel permanents \u00e0 temps plein au 31 mars 2026 \u00e9tait de 130. \u00c0 l\u2019occasion, le Partenariat fait appel [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"menu_order":0,"template":"","corporate_documents_categories":[1038],"class_list":["post-54738","corporate-documents","type-corporate-documents","status-publish","hentry","corporate_documents_categories-performance-et-responsabilisation"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Canadian Partnership Against Cancer<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\" \/>\n<meta property=\"og:description\" content=\"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 18 968 234 $ pour l\u2019ann\u00e9e civile close le 31 d\u00e9cembre 2025. 2. Le nombre total de membres du personnel permanents \u00e0 temps plein au 31 mars 2026 \u00e9tait de 130. \u00c0 l\u2019occasion, le Partenariat fait appel [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Partnership Against Cancer\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-20T23:18:32+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@cancerstratca\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/\",\"url\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/\",\"name\":\"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\"},\"datePublished\":\"2022-07-22T13:05:43+00:00\",\"dateModified\":\"2026-07-20T23:18:32+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/fr\\\/about-us\\\/corporate-strategic-document\\\/remuneration\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Corporate Documents\",\"item\":\"https:\\\/\\\/www.partnershipagainstcancer.ca\\\/about-us\\\/corporate-strategic-document\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9mun\u00e9ration\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/#website\",\"url\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/\",\"name\":\"Canadian Partnership Against Cancer\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/dev.partnershipagainstcancer.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Canadian Partnership Against Cancer","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","og_locale":"fr_FR","og_type":"article","og_title":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","og_description":"1. Les d\u00e9penses annuelles totales consacr\u00e9es \u00e0 la r\u00e9mun\u00e9ration vers\u00e9e au personnel permanent \u00e0 temps plein s\u2019\u00e9levaient \u00e0 18 968 234 $ pour l\u2019ann\u00e9e civile close le 31 d\u00e9cembre 2025. 2. Le nombre total de membres du personnel permanents \u00e0 temps plein au 31 mars 2026 \u00e9tait de 130. \u00c0 l\u2019occasion, le Partenariat fait appel [&hellip;]","og_url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","og_site_name":"Canadian Partnership Against Cancer","article_publisher":"https:\/\/www.facebook.com\/CanadianPartnershipAgainstCancer\/","article_modified_time":"2026-07-20T23:18:32+00:00","twitter_card":"summary_large_image","twitter_site":"@cancerstratca","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","url":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/","name":"R\u00e9mun\u00e9ration - Canadian Partnership Against Cancer","isPartOf":{"@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website"},"datePublished":"2022-07-22T13:05:43+00:00","dateModified":"2026-07-20T23:18:32+00:00","breadcrumb":{"@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.partnershipagainstcancer.ca\/fr\/about-us\/corporate-strategic-document\/remuneration\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Corporate Documents","item":"https:\/\/www.partnershipagainstcancer.ca\/about-us\/corporate-strategic-document\/"},{"@type":"ListItem","position":2,"name":"R\u00e9mun\u00e9ration"}]},{"@type":"WebSite","@id":"https:\/\/dev.partnershipagainstcancer.ca\/#website","url":"https:\/\/dev.partnershipagainstcancer.ca\/","name":"Canadian Partnership Against Cancer","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/dev.partnershipagainstcancer.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/corporate-documents\/54738","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/corporate-documents"}],"about":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/types\/corporate-documents"}],"author":[{"embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/users\/24"}],"wp:attachment":[{"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/media?parent=54738"}],"wp:term":[{"taxonomy":"corporate_documents_categories","embeddable":true,"href":"https:\/\/www.partnershipagainstcancer.ca\/fr\/wp-json\/wp\/v2\/corporate_documents_categories?post=54738"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}